Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
67
REZI Quote, Financials, Valuation and Earnings
Last price:
$24.24
Seasonality move
:
-8.2%
Day range:
$22.93 - $23.47
52-week range:
$14.18 - $28.28
Dividend yield:
0%
P/E ratio:
73.09x
P/S ratio:
0.49x
P/B ratio:
1.21x
Volume:
952.4K
Avg. volume:
1.1M
1-year change:
6.8%
Market cap:
$3.5B
Revenue:
$6.8B
EPS (TTM):
$0.32
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.1B | $5.8B | $6.4B | $6.2B | $6.8B | |
| Revenue Growth (YoY) | 1.66% | 15.28% | 8.96% | -2.01% | 8.32% | |
| Cost of Revenues | $3.8B | $4.3B | $4.6B | $4.5B | $4.9B | |
| Gross Profit | $1.3B | $1.6B | $1.8B | $1.7B | $1.9B | |
| Gross Profit Margin | 25.89% | 27.1% | 27.72% | 27.17% | 28.12% | |
| R&D Expenses | $77M | $86M | $111M | $109M | $111M | |
| Selling, General & Admin | $925M | $909M | $974M | $960M | $1.1B | |
| Other Inc / (Exp) | -$147M | -$159M | -$174M | -$211M | -$270M | |
| Operating Expenses | $1B | $1B | $1.1B | $1.1B | $1.3B | |
| Operating Income | $311M | $559M | $646M | $589M | $572M | |
| Net Interest Expenses | $63M | $47M | $54M | $65M | $81M | |
| EBT. Incl. Unusual Items | $101M | $353M | $418M | $313M | $221M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $64M | $111M | $135M | $103M | $105M | |
| Net Income to Company | $37M | $242M | $283M | $210M | $116M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $37M | $242M | $283M | $210M | $116M | |
| Basic EPS (Cont. Ops) | $0.30 | $1.68 | $1.94 | $1.43 | $0.62 | |
| Diluted EPS (Cont. Ops) | $0.29 | $1.63 | $1.90 | $1.42 | $0.61 | |
| Weighted Average Basic Share | $125.3M | $144M | $146M | $147M | $146M | |
| Weighted Average Diluted Share | $126.3M | $148M | $149M | $148M | $149M | |
| EBITDA | $250M | $488M | $566M | $476M | $446M | |
| EBIT | $164M | $400M | $472M | $378M | $302M | |
| Revenue (Reported) | $5.1B | $5.8B | $6.4B | $6.2B | $6.8B | |
| Operating Income (Reported) | $311M | $559M | $646M | $589M | $572M | |
| Operating Income (Adjusted) | $164M | $400M | $472M | $378M | $302M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.5B | $1.5B | $1.5B | $1.8B | |
| Revenue Growth (YoY) | 20.36% | 6.13% | 2.86% | -4.07% | 19.11% | |
| Cost of Revenues | $1.1B | $1.1B | $1.1B | $1.1B | $1.3B | |
| Gross Profit | $368M | $438M | $418M | $400M | $511M | |
| Gross Profit Margin | 25.93% | 29.08% | 26.99% | 26.92% | 28.87% | |
| R&D Expenses | $21M | $24M | $25M | $25M | $35M | |
| Selling, General & Admin | $217M | $236M | $244M | $231M | $306M | |
| Other Inc / (Exp) | -$44M | -$40M | -$42M | -$49M | -$100M | |
| Operating Expenses | $238M | $266M | $278M | $265M | $371M | |
| Operating Income | $130M | $172M | $140M | $135M | $140M | |
| Net Interest Expenses | $13M | $11M | $17M | $13M | $25M | |
| EBT. Incl. Unusual Items | $73M | $121M | $81M | $73M | $15M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $24M | $34M | $24M | $30M | $9M | |
| Net Income to Company | $49M | $87M | $57M | $43M | $6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $49M | $87M | $57M | $43M | $6M | |
| Basic EPS (Cont. Ops) | $0.34 | $0.60 | $0.39 | $0.29 | -$0.02 | |
| Diluted EPS (Cont. Ops) | $0.33 | $0.58 | $0.38 | $0.29 | -$0.02 | |
| Weighted Average Basic Share | $143.4M | $145M | $147M | $146M | $148M | |
| Weighted Average Diluted Share | $147.7M | $149M | $149M | $148M | $148M | |
| EBITDA | $109M | $152M | $122M | $110M | $87M | |
| EBIT | $86M | $132M | $98M | $86M | $40M | |
| Revenue (Reported) | $1.4B | $1.5B | $1.5B | $1.5B | $1.8B | |
| Operating Income (Reported) | $130M | $172M | $140M | $135M | $140M | |
| Operating Income (Adjusted) | $86M | $132M | $98M | $86M | $40M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.3B | $5.9B | $6.4B | $6.2B | $7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.9B | $4.3B | $4.7B | $4.5B | $5B | |
| Gross Profit | $1.4B | $1.6B | $1.7B | $1.7B | $2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $80M | $89M | $112M | $107M | $121M | |
| Selling, General & Admin | $910M | $930M | $982M | $947M | $1.2B | |
| Other Inc / (Exp) | -$149M | -$155M | -$176M | -$218M | -$321M | |
| Operating Expenses | $990M | $1B | $1.1B | $1.1B | $1.4B | |
| Operating Income | $407M | $601M | $614M | $584M | $577M | |
| Net Interest Expenses | $59M | $45M | $60M | $61M | $93M | |
| EBT. Incl. Unusual Items | $199M | $401M | $378M | $305M | $163M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $92M | $121M | $125M | $109M | $84M | |
| Net Income to Company | $107M | $280M | $253M | $196M | $79M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $107M | $280M | $253M | $196M | $79M | |
| Basic EPS (Cont. Ops) | $0.78 | $1.93 | $1.73 | $1.33 | $0.32 | |
| Diluted EPS (Cont. Ops) | $0.75 | $1.88 | $1.69 | $1.33 | $0.32 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $346M | $531M | $536M | $464M | $423M | |
| EBIT | $258M | $446M | $438M | $366M | $256M | |
| Revenue (Reported) | $5.3B | $5.9B | $6.4B | $6.2B | $7B | |
| Operating Income (Reported) | $407M | $601M | $614M | $584M | $577M | |
| Operating Income (Adjusted) | $258M | $446M | $438M | $366M | $256M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.5B | $1.5B | $1.5B | $1.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.1B | $1.1B | $1.1B | $1.1B | $1.3B | |
| Gross Profit | $368M | $438M | $418M | $400M | $511M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $21M | $24M | $25M | $25M | $35M | |
| Selling, General & Admin | $217M | $236M | $244M | $231M | $306M | |
| Other Inc / (Exp) | -$44M | -$40M | -$42M | -$49M | -$100M | |
| Operating Expenses | $238M | $266M | $278M | $265M | $371M | |
| Operating Income | $130M | $172M | $140M | $135M | $140M | |
| Net Interest Expenses | $13M | $11M | $17M | $13M | $25M | |
| EBT. Incl. Unusual Items | $73M | $121M | $81M | $73M | $15M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $24M | $34M | $24M | $30M | $9M | |
| Net Income to Company | $49M | $87M | $57M | $43M | $6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $49M | $87M | $57M | $43M | $6M | |
| Basic EPS (Cont. Ops) | $0.34 | $0.60 | $0.39 | $0.29 | -$0.02 | |
| Diluted EPS (Cont. Ops) | $0.33 | $0.58 | $0.38 | $0.29 | -$0.02 | |
| Weighted Average Basic Share | $143.4M | $145M | $147M | $146M | $148M | |
| Weighted Average Diluted Share | $147.7M | $149M | $149M | $148M | $148M | |
| EBITDA | $109M | $152M | $122M | $110M | $87M | |
| EBIT | $86M | $132M | $98M | $86M | $40M | |
| Revenue (Reported) | $1.4B | $1.5B | $1.5B | $1.5B | $1.8B | |
| Operating Income (Reported) | $130M | $172M | $140M | $135M | $140M | |
| Operating Income (Adjusted) | $86M | $132M | $98M | $86M | $40M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $517M | $775M | $326M | $636M | $692M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $863M | $876M | $1B | $973M | $1B | |
| Inventory | $672M | $740M | $975M | $941M | $1.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $173M | $150M | $199M | $193M | $220M | |
| Total Current Assets | $2.2B | $2.5B | $2.5B | $2.7B | $3.2B | |
| Property Plant And Equipment | $451M | $287M | $366M | $390M | $410M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.7B | $2.7B | $2.7B | $2.7B | $3.1B | |
| Other Intangibles | $135M | $120M | $475M | $461M | $1.2B | |
| Other Long-Term Assets | $108M | $244M | $320M | $346M | $369M | |
| Total Assets | $5.6B | $5.9B | $6.4B | $6.6B | $8.2B | |
| Accounts Payable | $936M | $883M | $894M | $905M | $1.1B | |
| Accrued Expenses | $197M | $167M | $219M | $164M | $193M | |
| Current Portion Of Long-Term Debt | -- | $10M | $12M | $12M | -- | |
| Current Portion Of Capital Lease Obligations | -- | $32M | $37M | $39M | $51M | |
| Other Current Liabilities | -- | -- | -- | -$1M | -- | |
| Total Current Liabilities | $1.5B | $1.5B | $1.5B | $1.5B | $1.8B | |
| Long-Term Debt | $1.2B | $1.2B | $1.4B | $1.4B | $2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.6B | $3.6B | $3.9B | $3.9B | $4.9B | |
| Common Stock | -- | -- | -- | -- | $482M | |
| Other Common Equity Adj | -$146M | -$165M | -$212M | -$194M | -$284M | |
| Common Equity | $2B | $2.3B | $2.5B | $2.7B | $2.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2B | $2.3B | $2.5B | $2.7B | $3.3B | |
| Total Liabilities and Equity | $5.6B | $5.9B | $6.4B | $6.6B | $8.2B | |
| Cash and Short Terms | $517M | $775M | $326M | $636M | $692M | |
| Total Debt | $1.2B | $1.2B | $1.4B | $1.4B | $2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $508M | $244M | $292M | $603M | $577M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $875M | $1B | $985M | $933M | $1B | |
| Inventory | $681M | $922M | $1B | $929M | $1.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $156M | $165M | $210M | $212M | $211M | |
| Total Current Assets | $2.2B | $2.3B | $2.5B | $2.7B | $3.1B | |
| Property Plant And Equipment | $307M | $350M | $379M | $369M | $411M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.7B | $3.1B | $2.7B | $2.7B | $3.1B | |
| Other Intangibles | -- | -- | $471M | $456M | $1.2B | |
| Other Long-Term Assets | $374M | $431M | $318M | $329M | $361M | |
| Total Assets | $5.6B | $6.2B | $6.4B | $6.5B | $8.1B | |
| Accounts Payable | $908M | $958M | $894M | $858M | $971M | |
| Accrued Expenses | $177M | $216M | $185M | $147M | $177M | |
| Current Portion Of Long-Term Debt | -- | -- | $12M | $12M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $38M | $38M | $51M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.4B | $1.5B | $1.5B | $1.4B | $1.6B | |
| Long-Term Debt | $1.2B | $1.4B | $1.4B | $1.4B | $2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.5B | $3.9B | $3.8B | $3.8B | $4.7B | |
| Common Stock | -- | -- | -- | -- | $482M | |
| Other Common Equity Adj | -$170M | -$151M | -$200M | -$226M | -$246M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2B | $2.4B | $2.6B | $2.8B | $3.3B | |
| Total Liabilities and Equity | $5.6B | $6.2B | $6.4B | $6.5B | $8.1B | |
| Cash and Short Terms | $508M | $244M | $292M | $603M | $577M | |
| Total Debt | $1.2B | $1.4B | $1.4B | $1.4B | $2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $37M | $242M | $283M | $210M | $116M | |
| Depreciation & Amoritzation | $86M | $88M | $94M | $98M | $144M | |
| Stock-Based Compensation | $29M | $39M | $50M | $44M | $59M | |
| Change in Accounts Receivable | -$27M | -$30M | -$72M | $19M | -$18M | |
| Change in Inventories | $19M | -$73M | -$122M | $32M | -$71M | |
| Cash From Operations | $244M | $315M | $152M | $440M | $444M | |
| Capital Expenditures | $70M | $63M | $85M | $105M | $80M | |
| Cash Acquisitions | -$35M | -$11M | -$665M | $70M | -$1.3B | |
| Cash From Investing | -$103M | -$65M | -$764M | -$44M | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.3B | $200M | -- | $1.2B | |
| Long-Term Debt Repaid | -$22M | -$1.2B | -$12M | -$12M | -$605M | |
| Repurchase of Common Stock | -- | -- | -- | -$41M | -$1M | |
| Other Financing Activities | -$4M | -$42M | -$18M | -$11M | -$21M | |
| Cash From Financing | $253M | $20M | $170M | -$64M | $1B | |
| Beginning Cash (CF) | $122M | $517M | $779M | $329M | $637M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $394M | $270M | -$442M | $332M | $66M | |
| Ending Cash (CF) | $517M | $779M | $329M | $637M | $693M | |
| Levered Free Cash Flow | $174M | $252M | $67M | $335M | $364M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $49M | $87M | $57M | $43M | $6M | |
| Depreciation & Amoritzation | $23M | $20M | $24M | $24M | $47M | |
| Stock-Based Compensation | $9M | $11M | $12M | $14M | $15M | |
| Change in Accounts Receivable | -$17M | -$61M | $23M | $34M | -$13M | |
| Change in Inventories | -$10M | -$66M | -$27M | $7M | $17M | |
| Cash From Operations | $5M | -$59M | -$4M | $2M | -$65M | |
| Capital Expenditures | $19M | $19M | $20M | $21M | $31M | |
| Cash Acquisitions | -$5M | -$633M | -$6M | -- | -- | |
| Cash From Investing | -$24M | -$665M | -$26M | -$22M | -$31M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $950M | $200M | -- | -- | -- | |
| Long-Term Debt Repaid | -$921M | -$3M | -$3M | -$3M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$7M | -$15M | |
| Other Financing Activities | -$16M | -$8M | -$6M | $2M | $2M | |
| Cash From Financing | $13M | $189M | -$9M | -$8M | -$22M | |
| Beginning Cash (CF) | $517M | $779M | $329M | $637M | $693M | |
| Foreign Exchange Rate Adjustment | -$3M | -- | $6M | -$5M | $3M | |
| Additions / Reductions | -$6M | -$535M | -$39M | -$28M | -$118M | |
| Ending Cash (CF) | $508M | $244M | $296M | $604M | $578M | |
| Levered Free Cash Flow | -$14M | -$78M | -$24M | -$19M | -$96M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $107M | $280M | $253M | $196M | $79M | |
| Depreciation & Amoritzation | $88M | $85M | $98M | $98M | $167M | |
| Stock-Based Compensation | $31M | $41M | $51M | $46M | $60M | |
| Change in Accounts Receivable | -$27M | -$74M | $12M | $30M | -$65M | |
| Change in Inventories | $15M | -$129M | -$83M | $66M | -$61M | |
| Cash From Operations | $323M | $251M | $207M | $446M | $377M | |
| Capital Expenditures | $73M | $63M | $86M | $106M | $90M | |
| Cash Acquisitions | -$5M | -$639M | -$38M | $76M | -$1.3B | |
| Cash From Investing | -$76M | -$706M | -$125M | -$40M | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $600M | $500M | -- | -- | -- | |
| Long-Term Debt Repaid | -$943M | -$270M | -$12M | -$12M | -$602M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$9M | |
| Other Financing Activities | -$19M | -$34M | -$16M | -$3M | -$21M | |
| Cash From Financing | -$83M | $196M | -$28M | -$63M | $1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $164M | -$259M | $54M | $343M | -$24M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $250M | $188M | $121M | $340M | $287M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $49M | $87M | $57M | $43M | $6M | |
| Depreciation & Amoritzation | $23M | $20M | $24M | $24M | $47M | |
| Stock-Based Compensation | $9M | $11M | $12M | $14M | $15M | |
| Change in Accounts Receivable | -$17M | -$61M | $23M | $34M | -$13M | |
| Change in Inventories | -$10M | -$66M | -$27M | $7M | $17M | |
| Cash From Operations | $5M | -$59M | -$4M | $2M | -$65M | |
| Capital Expenditures | $19M | $19M | $20M | $21M | $31M | |
| Cash Acquisitions | -$5M | -$633M | -$6M | -- | -- | |
| Cash From Investing | -$24M | -$665M | -$26M | -$22M | -$31M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $950M | $200M | -- | -- | -- | |
| Long-Term Debt Repaid | -$921M | -$3M | -$3M | -$3M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$7M | -$15M | |
| Other Financing Activities | -$16M | -$8M | -$6M | $2M | $2M | |
| Cash From Financing | $13M | $189M | -$9M | -$8M | -$22M | |
| Beginning Cash (CF) | $517M | $779M | $329M | $637M | $693M | |
| Foreign Exchange Rate Adjustment | -$3M | -- | $6M | -$5M | $3M | |
| Additions / Reductions | -$6M | -$535M | -$39M | -$28M | -$118M | |
| Ending Cash (CF) | $508M | $244M | $296M | $604M | $578M | |
| Levered Free Cash Flow | -$14M | -$78M | -$24M | -$19M | -$96M | |
Get REZI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
REZI
Sector
P/E ratio
73.09x
18.58x
PEG ratio
--
0.25x
P/B ratio
1.21x
1.75x
Price / LTM sales
0.49x
0.94x
Growth Metrics
REZI
Sector
Revenue growth
19.11%
1.98%
Earnings growth
-85.71%
2.46%
Revenue (5-year growth)
6.27%
4.35%
Earnings forecast
$0.54
$0.40
Profitability
REZI
Sector
Profitability FY 2024
$1.9B
$393.9M
Return on invested capital
1.55%
5.32%
Return on assets
1.02%
3.49%
Return on equity
2.46%
8.55%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
5
Estimated Next Earnings Date
Aug
5
Balance Sheet
REZI
Sector
Total cash
$577M
$154.3M
Short term investments
--
$35.5M
Total assets
$8.2B
$1.7B
Long term debt
$2B
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
